These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24468615)

  • 1. Assessment of raloxifene, estradiol-17β, dl-ormeloxifene and levormeloxifene on thrombin activity.
    Surin WR; Bhalla H; Kuriakose GC; Singh MM
    J Basic Clin Physiol Pharmacol; 2014 Jan; ():1-8. PubMed ID: 24468615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene.
    Dwivedi A; Basu R; Chowdhury SR; Goyal N
    Contraception; 2005 Jun; 71(6):458-64. PubMed ID: 15914137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro.
    Mann V; Huber C; Kogianni G; Collins F; Noble B
    Bone; 2007 Mar; 40(3):674-84. PubMed ID: 17174166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro.
    Taranta A; Brama M; Teti A; De luca V; Scandurra R; Spera G; Agnusdei D; Termine JD; Migliaccio S
    Bone; 2002 Feb; 30(2):368-76. PubMed ID: 11856644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
    Gogos A; van den Buuse M
    Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension.
    Abdulkareem AO; Tiwari P; Lone ZR; Iqbal H; Gupta S; Jha RK; Chanda D; Jagavelu K; Hanif K
    Eur J Pharmacol; 2023 Mar; 943():175558. PubMed ID: 36731722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
    Suuronen T; Nuutinen T; Huuskonen J; Ojala J; Thornell A; Salminen A
    Inflamm Res; 2005 May; 54(5):194-203. PubMed ID: 15953991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulator effects in the rat brain.
    Zhou W; Koldzic-Zivanovic N; Clarke CH; de Beun R; Wassermann K; Bury PS; Cunningham KA; Thomas ML
    Neuroendocrinology; 2002 Jan; 75(1):24-33. PubMed ID: 11810032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene plus 17beta-estradiol inhibits proliferation of primary cultured vascular smooth muscle cells and human mammary endothelial cells via the janus kinase/signal transducer and activator of transcription3 cascade.
    Wang TH; Xiang QL; Chen JW; Pan H; Cui YH
    Eur J Pharmacol; 2007 Apr; 561(1-3):7-13. PubMed ID: 17336289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
    Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
    J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
    Michael H; Härkönen PL; Kangas L; Väänänen HK; Hentunen TA
    Br J Pharmacol; 2007 Jun; 151(3):384-95. PubMed ID: 17420779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular effects of selective estrogen receptor modulators.
    Christodoulakos GE; Lambrinoudaki IV; Botsis DC
    Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
    Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro.
    Hall TJ; Nyugen H; Schaueblin M; Fournier B
    Biochem Biophys Res Commun; 1995 Nov; 216(2):662-8. PubMed ID: 7488162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Estrogen Receptor Modulators (SERMs) Synergize with Cisplatin, Induce Apoptosis and Suppress Cellular Migration and Colony Formation of Lung Cancer Cells.
    Alsous L; Bardaweel S
    Anticancer Agents Med Chem; 2022; 22(9):1826-1836. PubMed ID: 35546505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulators prevent neointima formation after vascular injury.
    Savolainen-Peltonen H; Luoto NM; Kangas L; Häyry P
    Mol Cell Endocrinol; 2004 Nov; 227(1-2):9-20. PubMed ID: 15501580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures.
    Benvenuti S; Luciani P; Vannelli GB; Gelmini S; Franceschi E; Serio M; Peri A
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1775-82. PubMed ID: 15585566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERbeta-selective SERMs produce mnemonic-enhancing effects in the inhibitory avoidance and water maze tasks.
    Rhodes ME; Frye CA
    Neurobiol Learn Mem; 2006 Mar; 85(2):183-91. PubMed ID: 16326119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathway.
    Richardson MA; Berg DT; Calnek DS; Ciaccia AV; Joyce DE; Grinnell BW
    Endocrinology; 2000 Oct; 141(10):3908-11. PubMed ID: 11014248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.